Biologic Therapy for Osteoarthritis in Simi Valley, CA

What I’d check before adding osteoarthritis biologic therapy here

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 10.3% of adults in Simi Valley have diagnosed diabetes — 1.7 points below the U.S. 12% figure. 7.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick osteoarthritis biologic therapy against that mix.

Where Simi Valley programs actually stall

• Adult arthritis here is 21% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 7.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in California.
• Undiagnosed diabetes is 27.6% of U.S. adults who have the disease (CDC). Wound and joint programs in California will see patients who were never labeled diabetic on the referral — screening and offloading still belong in the protocol.
• California Department of Public Health publishes state chronic-disease context that clinics can cite in patient education. Pair that with FDA 361 labeling — homologous use, minimal manipulation — so marketing does not outrun the product's actual regulatory lane.

Uninsured mix and Medicare CTPs in the same building

America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Simi Valley we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 10.3% of adults in Simi Valley have diagnosed diabetes — 1.7 points below the U.S. 12% figure.

How we’d stand this up in clinic